Last Updated: May 10, 2026

Details for Patent: 3,634,583


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,634,583
Title:Pharmaceutical composition for the treatment of oedematous conditions and hypertension
Abstract:THE INVENTION RELATES TO DIURETIC AND SALURETIC PREPARATIONS IN DOSAGE UNIT FORM, CONTAINING THE HITHERTO UNKNOWN 3-BUTYLAMINO-4-PHENOXY-5-SULFAMYL-BENZOIC ACID OR SALT THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE BASE AS THE ACTIVE COMPONENT, IF DESIRED TOGETHER WITH A HYPOTENSOR, THE DOSE OF THE DIURETIC BEING BETWEEN 0.1 AND 10 MG. CALCULATED AS THE FREE ACID.
Inventor(s):Peter Werner Feit
Assignee: Leo Pharma AS
Application Number:US845939A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

What Does US Patent 3,634,583 Claim, and How Does It Map Into the US Landscape?

No actionable analysis can be produced from the information provided. The record is incomplete: the patent number (3,634,583) is given, but the claims text is not provided (“The claims are:” is empty). Without the claim language (and without the full bibliographic record of the patent file history), scope, novelty position, and infringement-relevant claim construction cannot be completed.

Key Takeaways

  • The claim set for US 3,634,583 is required to analyze scope, dependencies, and term of protection.
  • A defensible US landscape view requires the actual claims plus bibliographic details (assignee, filing date, expiration/term status, continuation or reissue status, and prosecution history).

FAQs

  1. Can claim-scope analysis be done without the claim text? No.
  2. What inputs determine the US patent landscape impact? The issued claim language and the patent’s legal status and family/prosecution history.
  3. What does “scope” mean in patent-landscape terms? The literal and doctrine-of-equivalents boundaries set by claim terms and their informed construction.
  4. Why is the claims section the gating item? Landscape relevance (white-space, overlap, and design-around) is claim-driven.
  5. What can be analyzed once the claims are provided? Independent claim scope, dependent-claim restrictions, likely claim charts, and overlap with nearby US filings and cited patents.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 3,634,583

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.